A detailed history of Royal Bank Of Canada transactions in Codexis, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 268,793 shares of CDXS stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
268,793
Previous 251,372 6.93%
Holding current value
$1.38 Million
Previous $779,000 6.16%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.62 - $3.71 $45,643 - $64,631
17,421 Added 6.93%
268,793 $827,000
Q2 2024

Aug 14, 2024

BUY
$2.65 - $3.92 $143,394 - $212,115
54,111 Added 27.43%
251,372 $779,000
Q1 2024

Nov 05, 2024

SELL
$2.59 - $4.65 $140,147 - $251,616
-54,111 Reduced 21.53%
197,261 $688,000
Q1 2024

May 15, 2024

BUY
$2.59 - $4.65 $101,206 - $181,703
39,076 Added 24.7%
197,261 $688,000
Q4 2023

Feb 14, 2024

BUY
$1.54 - $3.37 $53,752 - $117,626
34,904 Added 28.31%
158,185 $482,000
Q3 2023

Nov 14, 2023

BUY
$1.5 - $3.75 $4,422 - $11,055
2,948 Added 2.45%
123,281 $233,000
Q2 2023

Aug 14, 2023

BUY
$2.21 - $4.43 $105,903 - $212,285
47,920 Added 66.18%
120,333 $336,000
Q1 2023

May 15, 2023

BUY
$3.81 - $6.76 $90,971 - $161,408
23,877 Added 49.19%
72,413 $299,000
Q4 2022

Feb 14, 2023

SELL
$4.26 - $6.84 $3,565 - $5,725
-837 Reduced 1.7%
48,536 $226,000
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $84,912 - $180,194
14,012 Added 39.63%
49,373 $299,000
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $112,474 - $294,858
13,470 Added 61.53%
35,361 $370,000
Q1 2022

May 16, 2022

BUY
$16.97 - $31.93 $46,175 - $86,881
2,721 Added 14.19%
21,891 $451,000
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $194,917 - $317,987
-7,611 Reduced 28.42%
19,170 $600,000
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $39,024 - $55,588
1,986 Added 8.01%
26,781 $623,000
Q2 2021

Aug 16, 2021

BUY
$17.48 - $25.46 $433,416 - $631,280
24,795 New
24,795 $562,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.